Huh? I've never spoken with Gene, I posted his email in which he wrote he expected non-approval from fda, that is still there at IV. Attack and blame me if it makes you feel better, but it's wiser to own up to one's mistakes as I do and have. The rest of that email indicated he expected a path to approval back then. Good luck to you, Wolfdoogy.
Klingon, the selling prices can be deduced from the financials, CG were sold to Turkey for
$6.77 and Luviva for about $14k, nearly breakeven, while CG acq. cost is around $2.80. CG are sold at various prices depending on order size. Co. made some gm Q1 because many CG were shipped. Look at inventory details in 10q and a/r.
Personal attacks don't add value here. I read today's 8k from navb and it does look quite ominous. The lender that sued navb may be able to go after alternate financing as well. Still, I think the stock will recover nicely once this smoke clears. navb can get financing to pay off the lender, and with more friendly covenants as well.
I sent people to iv cause it's a good mb with links at top and in msg bodies, to get good info. What anyone does with the info is on them. Yahoo mb really stink. I read every filing, and listened to every teleconference to get info but still lost on gthp stock.
I'm always honest, sometimes wrong, no guarantees ever in stocks, but navb should at least double from here, in time. I bought some. What have you ever been correct about?
Oh right, nothing.
I know this one very well, have some patience, it will do great from today's 86 cents.
Bad news is priced in, heavy short interest, rest of year will be much better imo.
Why don't you be honest, Lilith? Your opinions of me mean less than nothing.
I've been honest the entire time here.
How much did you lose on gthp?
I admitted my mistakes with candor.
Hey F., I'll follow this story til I die. Hologix? I just hope whoever tries Luviva next has good mgmt and a strong balance sheet. I always look at balance sheet b4 I touch any stock - my mistake was believing big numbers revenues would have arrived well before now. When they did the ugly financing in the .40s I should have got and stayed out but I guess I lost my discipline.
Curious where Gene ends up too, probably on some golf course - groundskeepers are always in demand.
Lilith probably lost all her money in gthp too, why she's bitter and has been bashing it so long.
I didn't start buying any in size til .10 presplit and even then not much. Made a few k trading it, helped a little, haven't been able to trade it even, for a long time, it just goes straight down.
Maybe we can make it back via the co. that ends up with the patents.
they're selling low because they got the shares for free and
they know the common stock is going to zero. Same with the warrants.
but my huge Q is who the heck is buying all the shares?
I've been asking that for months and I can't deduce any valid answer.
Sure the buyers can pay in advance and help finance but they have not.
The awful financings killed the company.
The Turks bought large they know they can get the cervical guides
I believe the Luviva device will survive, but will have new owners -
the only thing that can save the common stock is huge new orders.
The IP will be owned by the lender in a default and they'll quickly sell it
to a diagnostics company, most likely, but hey I can't predict the future
I can only hypothesize from facts given in filings.
Preferred stock is much like a loan, more debt than stock,
and they got sweet deals for buying it.
The higher the risk the higher the rate and the worse the terms of a loan for the debtor co.
Geno didn't understand the repricing when he signed the deal, he said so,
and laments what he did. He'll lose a mil of his own money, most likely.
The financings are complex.
a cpa, seanoise, and I both calculated a few months ago that fully diluted outstanding shares is over 400m, with 1b authorized, pre-split.
Post-split, still 1b authorized.
% Change from Prev
Avg Daily Vol
Days to Cover
03/31/2016 GUIDED THERAPEUTICS INC Common GTHP OTCBB 7,709 12,326 -4,617 -37.46 115,096 1
They did the r/s because bigs couldn't buy such a cheap stock due to regs. so they had to do that to have any chance of secondary. Issuing or converting preferreds had nothing to do with it. Having enuf common to convert to required raising authorized shares. You knew it was coming because co. said it would and mentioned it in PRs, filings.
Not that it matters why they did it.
Aquarius can't buy stocks under a dime per rules there or their prospectus.
Now IF IF IF the co. can get $12M of solid orders then they might execute financing but even then it would be punishing.
Just invest in the company that ends up with the patents, the lender won't hold them long after default and yeah, it might be all pre-arranged.
I think the tech has a chance to succeed bigtime - In the Right hands.
Gene is done, he'll never get another job after this fiasco, he had no freakin clue what he signed when he agreed to the shark fin. I sent him the article about Magna, the thieves, but yo it's legal.
Beta, read the recent S1 in which holders have filed to sell millions of shares. One co.
converted to millions of common probably so they can sell, too.
My biggest question is who is buying all these shares and why? Takes 2 to trade.
Only a miracle can save it from bankruptcy now.
Much more likely and sensible is for a company to own the IP, patents,
and not invest in the company.
SEC filings don't lie.
My plan is to invest in the company that ends up with the IP.
Read the gthp filing which states it is a conversion, probably preferred to common.
It's at sec.gov, I put the link directly to gthp filings at top of iv mb.
Or it may have been debt to common, I didn't check and don't recall this co.
That was a conversion, see sec.gov guided therapeutics.
S1 also filed for selling parties, millions of shares, in effect.